A trio of papers shows that specialized antibodies can direct T cells to destroy cells that display portions of mutant cancer-related proteins, as well as T cells that have become cancerous themselves.

Death rates among blood cancer patients who contract COVID-19 are higher than for those with other cancers, pointing to impaired immunity that makes it hard to overcome the virus.

The oncologist developed lifesaving childhood leukemia treatments and revolutionized chemotherapy.

Infusions of donor T cells to fight the cancer often fail, but sodium bicarbonate can counter lactic acid produced by leukemia cells, potentially improving remission rates in mice and humans.

A cancer researcher with a talent for leadership, Marks turned the Memorial Sloan Kettering Cancer Center into one of the world’s foremost oncology research institutions.

Through his studies on cancer-causing viruses, the University of California, Los Angeles, professor has helped develop lifesaving treatments.

Targeting the transient group of cells could prevent recurrence of the disease.

Combining data from the genetic testing techniques can guide patient care, scientists say.

An investigation by Politico finds the agency has been sitting on an assessment of formaldehyde’s cancer risks for a year and a half.

Early exposure to common microbes could stop leukemia from manifesting in children.

Mutations in the TP53 gene appear to influence the prognosis and likelihood of future cancers in pediatric leukemia patients.

Two large-scale studies reveal new insights into the genomic characteristics of childhood cancers.

The immunotherapy, which targets CD22 on cancer cells rather than CD19, might prove useful in patients for whom previous T-cell treatments were unsuccessful. 

The genetically modified blood cells will be used for patients with a type of acute lymphoblastic leukemia, when other treatments fail.

High levels of vitamin C absorbed by blood-forming stem cells are important for their normal development. 

High-dose vitamin C injections reverse the effects of a leukemia-promoting genetic deficiency.

In the latest findings from the Reproducibility Project: Cancer Biology, independent researchers achieve results that mirror those of two earlier papers.

Researchers identify transcription factors and environmental conditions necessary to reprogram human and mouse cells into cells that function like hematopoietic stem cells.

Artificial bones produce new blood cells in mice, obviating the need for irradiation to kill off resident hematopoietic stem cells in recipients.